Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Total Assets : ¥12,250 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Total Assets?

Zhejiang Jiuzhou Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥12,250 Mil.

During the past 12 months, Zhejiang Jiuzhou Pharmaceutical Co's average Total Assets Growth Rate was 18.30% per year. During the past 3 years, the average Total Assets Growth Rate was 18.00% per year. During the past 5 years, the average Total Assets Growth Rate was 20.00% per year. During the past 10 years, the average Total Assets Growth Rate was 16.40% per year.

During the past 13 years, Zhejiang Jiuzhou Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 35.80%. The lowest was -0.90%. And the median was 22.50%.

Total Assets is connected with ROA %. Zhejiang Jiuzhou Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 8.20%. Total Assets is also linked to Revenue through Asset Turnover. Zhejiang Jiuzhou Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.13.

Zhejiang Jiuzhou Pharmaceutical Co Total Assets Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Total Assets Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

4,670.28

5,003.51

7,040.42

7,913.71

10,851.99

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															10,954.90	11,335.88	11,294.59	10,851.99	12,249.81

Zhejiang Jiuzhou Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Zhejiang Jiuzhou Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	8533.071	+	2318.916
	=	10,852

Zhejiang Jiuzhou Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	8735.802	+	3514.004
	=	12,250

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Total Assets Explanation

Total Assets is connected with ROA %.

Zhejiang Jiuzhou Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	947.036	/	( (10851.987	+	12249.806)	/ 2 )
	=	947.036	/	11550.8965
	=	8.20 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Zhejiang Jiuzhou Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	1475.744	/	( (10851.987	+	12249.806)	/ 2 )
=	1475.744	/	11550.8965
=	0.13

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Zhejiang Jiuzhou Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000

Website

http://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Executives

Sha Yu Jie	Directors, senior managers
Mei Yi Jiang	Director
Li Yuan Qiang	senior management
Yang Nong Gang	senior management
	Directors, senior managers
Huang Min Xia	senior management
Wang Bin	Directors, senior managers
Dai Yun You	senior management
Jiang Zu Lin	Directors, senior managers
Guo Zhen Rong	senior management
Chen Zhi Hong	Directors, senior managers
Xu Jia Jun	Supervisors
Hua Li Rong	Director
Lin Hui Lu	senior management
Zhu Guo Liang	Supervisors

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines